Mark A. Laughlin

Person

Sandy, UT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Piperazine derivatives useful as CCR5 antagonists
- Patent number 8,114,879
- Issue date Feb 14, 2012
- Schering Corporation
- Bahige M. Baroudy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperazine derivatives useful as CCR5 antagonists
- Patent number 7,384,944
- Issue date Jun 10, 2008
- Schering Corporation
- Bahige M. Baroudy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pegylated interferon alfa-CCR5 antagonist combination HIV therapy
- Patent number 7,247,631
- Issue date Jul 24, 2007
- Schering Corporation
- Mark A. Laughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperazine derivatives useful as CCR5 antagonists
- Patent number 6,689,765
- Issue date Feb 10, 2004
- Schering Corporation
- Bahige M. Baroudy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pegylated interferon alfa-CCR5 antagonist combination HIV therapy
- Patent number 6,635,646
- Issue date Oct 21, 2003
- Schering Corporation
- Mark A. Laughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperidine derivatives useful as CCR5 antagonists
- Patent number 6,602,885
- Issue date Aug 5, 2003
- Schering Corporation
- Bahige M. Baroudy
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine derivatives useful as CCR5 antagonists
- Patent number 6,387,930
- Issue date May 14, 2002
- Schering Corporation
- Bahige M. Baroudy
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PIPERIDINE DERIVATIVES USEFUL AS CCR5 ANTAGONISTS
- Publication number 20080188485
- Publication date Aug 7, 2008
- Schering Corporation
- Bahige M. Baroudy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of treating overactive bladder and urinary incontinence
- Publication number 20070015832
- Publication date Jan 18, 2007
- Myriad Genetics, Incorporated
- Mark Laughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of treating interferon non-responders using HCV protease inh...
- Publication number 20070004635
- Publication date Jan 4, 2007
- Schering Corporation
- Janice K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pegylated interferon alfa-CCR5 antagonist combination HIV therapy
- Publication number 20040076609
- Publication date Apr 22, 2004
- Mark A. Laughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperazine derivatives useful as CCR5 antagonists
- Publication number 20040067961
- Publication date Apr 8, 2004
- Bahige M. Baroudy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treating fungal infections
- Publication number 20040058974
- Publication date Mar 25, 2004
- Schering Corporation
- Rachel Courtney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperazine derivatives useful as CCR5 antagonists
- Publication number 20030069252
- Publication date Apr 10, 2003
- Bahige M. Baroudy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperidine derivatives useful as CCR5 antagonists
- Publication number 20030004185
- Publication date Jan 2, 2003
- Bahige M. Baroudy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIV Therapy
- Publication number 20020182179
- Publication date Dec 5, 2002
- Mark A Laughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIV immune adjuvant therapy
- Publication number 20020004584
- Publication date Jan 10, 2002
- Mark A. Laughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mark A. Laughlin

Person

Patents Grantslast 30 patents

Piperazine derivatives useful as CCR5 antagonists

Piperazine derivatives useful as CCR5 antagonists

Pegylated interferon alfa-CCR5 antagonist combination HIV therapy

Piperazine derivatives useful as CCR5 antagonists

Pegylated interferon alfa-CCR5 antagonist combination HIV therapy

Piperidine derivatives useful as CCR5 antagonists

Piperidine derivatives useful as CCR5 antagonists

Patents Applicationslast 30 patents

PIPERIDINE DERIVATIVES USEFUL AS CCR5 ANTAGONISTS

Methods of treating overactive bladder and urinary incontinence

Method of treating interferon non-responders using HCV protease inh...

Pegylated interferon alfa-CCR5 antagonist combination HIV therapy

Piperazine derivatives useful as CCR5 antagonists

Treating fungal infections

Piperazine derivatives useful as CCR5 antagonists

Piperidine derivatives useful as CCR5 antagonists

HIV Therapy

HIV immune adjuvant therapy